Biblio Discovery — Demo Discovery Service

9 results for "Li-Qiang Meng"

Showing 1–9 · 0.08 seconds · RSS

  1. Journal Article Full text

    p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation.

    Jian Hao; Li-Qiang Meng; Peng-Cheng Xu et al.

    PLoS ONE, Vol. 7 No. 5 · 2012 · English · DOAJ Scopus

    BACKGROUND: The complement system is one of the important contributing factors in the development of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). C5a and the neutrophil C5a receptor play a central role in antineutrophil cytoplasmic antibody (ANCA)-mediated neutrophil…

  2. Journal Article

    Rituximab Therapy for Primary Membranous Nephropathy in a Chinese Cohort

    Shuang Gao; Zhao Cui; Xin Wang et al.

    Frontiers in Medicine, Vol. 8 · 2021 · English · DOAJ Scopus

    Background: Rituximab has become one of the first-line therapies for the treatment of moderate and high-risk primary membranous nephropathy (pMN). We retrospectively reviewed 95 patients with pMN who received rituximab therapy and focused on the therapeutic effects and safety of this therapy in a…

  3. Journal Article

    Risk factors for relapse and aggravation in membranous nephropathy after COVID-19 infection

    Yue Shu; Jing Huang; Yi-miao Zhang et al.

    BMC Nephrology, Vol. 26 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Background Relapse of membranous nephropathy (MN) and other glomerular diseases has been observed after COVID-19 infection. The risk factors contributing to disease progression in MN patients after contracting COVID-19 remain unclear. Methods This retrospective study included 656…

  4. Journal Article

    The quantifying relationship between the remission duration and the cardiovascular and kidney outcomes in the patients with primary nephrotic syndrome

    Xuan Lai; Zhao Cui; Hua Zhang et al.

    Renal Failure, Vol. 44 No. 1 · 2022 · English · DOAJ Scopus

    Background Patients with persistent nephrotic-range proteinuria have a high risk of kidney dysfunction and cardiovascular events. Recently, the maintenance of proteinuria remission has been demonstrated to reduce the risk of kidney endpoint. However, the effect of remission duration on…

  5. Journal Article

    Complement activation products in the circulation and urine of primary membranous nephropathy

    Mu-fan Zhang; Jing Huang; Yi-miao Zhang et al.

    BMC Nephrology, Vol. 20 No. 1 · 2019 · English · DOAJ Scopus

    Abstract Background Complement activation plays a substantial role in the pathogenesis of primary membranous nephropathy (pMN). C5b-9, C3c, MBL, and factor B have been documented in the subepithelial immune deposits. However, the changing of complement activation products in circulation and urine…

  6. Journal Article

    Complement activation profile of patients with primary focal segmental glomerulosclerosis.

    Jing Huang; Zhao Cui; Qiu-Hua Gu et al.

    PLoS ONE, Vol. 15 No. 6 · 2020 · English · DOAJ Scopus

    BackgroundStudies on adriamycin mice model suggest complement system is activated and together with IgM contributes to the glomerular injury of primary focal segmental glomerulosclerosis (FSGS). We recently reported primary FSGS patients with IgM and C3 deposition showed unfavorable therapeutic…

  7. Journal Article

    Safety and efficacy of sirolimus combined with cyclosporine in primary membranous nephropathy: a randomized controlled trial

    Fang Wang; Chao Yang; Yue Shu et al.

    BMC Medicine, Vol. 23 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Background Calcineurin inhibitors, such as cyclosporine, are primary treatments for membranous nephropathy (MN). Optimizing this regimen is crucial to reduce nephrotoxicity and enhance immunological remission. Sirolimus, when combined with cyclosporine, may offer non-inferior clinical…

  8. Journal Article

    Clinical implications of pathological features of primary membranous nephropathy

    Xiao-dan Zhang; Zhao Cui; Mu-fan Zhang et al.

    BMC Nephrology, Vol. 19 No. 1 · 2018 · English · DOAJ Scopus

    Abstract Background The clinical outcome varies considerably in primary membranous nephropathy (pMN). Risk factors for kidney prognosis include ageing, male gender, persistent heavy proteinuria, decreased eGFR at presentation, persistent elevation of anti-PLA2R antibodies, no remission, and so on…